65.69
+0.20
+(0.31%)
As of 8:25:20 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 18 | 16 | 25 | 25 |
| Avg. Estimate | 5.06B | 5.12B | 20.56B | 21.57B |
| Low Estimate | 5.02B | 5.05B | 19.74B | 20.66B |
| High Estimate | 5.1B | 5.15B | 21.02B | 22.05B |
| Year Ago Sales | 4.76B | 4.85B | 19.74B | 20.56B |
| Sales Growth (year/est) | 6.29% | 5.47% | 4.18% | 4.92% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| COZ.F | -- | -- | -- | -- |
| S&P 500 | 6.52% | 6.29% | 9.55% | 14.25% |
Upgrades & Downgrades
| Maintains | Baird: Neutral to Neutral | 4/8/2025 |
| Reiterates | Needham: Hold to Hold | 3/27/2025 |
| Reiterates | RBC Capital: Sector Perform to Sector Perform | 3/26/2025 |
| Maintains | UBS: Neutral to Neutral | 3/17/2025 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 3/12/2025 |
| Maintains | Barclays: Overweight to Overweight | 2/10/2025 |